SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Dec 16, 2016
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: Dec. 16, 2016 · CIK: 0001585608 · Accession: 0001104659-16-162574
AI Filing Summary & Sentiment
File numbers found in text: 333-214956
Show Raw Text
CORRESP 1 filename1.htm December 16, 2016 Via Email and EDGAR Suzanne Hayes Assistant Director U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Jaguar Animal Health, Inc. Registration Statement on Form S-1 File No. 333-214956 Ladies and Gentlemen: Jaguar Animal Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission (the “Commission”) on December 19, 2016, at 4:00 p.m., Eastern Standard Time, or as soon thereafter as is practicable. Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358. Very truly yours, Jaguar Animal Health, Inc. /s/ Lisa A. Conte Lisa A. Conte Chief Executive Officer and President Jaguar Animal Health, Inc. · 201 Mission Street, Suite 2375 · San Francisco, CA 94105 Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311 · www.jaguaranimalhealth.com